Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 7/2010

01-07-2010 | Original paper

Family history and lung cancer risk: international multicentre case–control study in Eastern and Central Europe and meta-analyses

Authors: Jolanta Lissowska, Lenka Foretova, Joanna Dąbek, David Zaridze, Neonila Szeszenia-Dabrowska, Peter Rudnai, Eleonora Fabianova, Adrian Cassidy, Dana Mates, Vladimir Bencko, Vladimir Janout, Rayjean J. Hung, Paul Brennan, Paolo Boffetta

Published in: Cancer Causes & Control | Issue 7/2010

Login to get access

Abstract

Lung cancer is the most common neoplastic disease in Eastern and Central Europe. The role of hereditary factors in lung carcinogenesis is not fully understood. Family history (FH) of lung cancer and other tobacco-related cancers might be a strong predictor of the lung cancer risk. We investigated family history of cancer among first-degree relatives of 2,861 patients with lung cancer and 3,118 controls from the Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, and United Kingdom within the IARC Multicenter Case–Control Study. Odds ratios (ORs) and 95% CI were calculated using logistic regression, adjusting for age, gender, study center, education, tobacco smoking, and number of first-degree relatives. In addition, we conducted a meta-analysis of 41 studies on FH of cancer and lung cancer risk. Positive FH of lung cancer increased risk of lung cancer with OR of 1.63 (95%CI: 1.31–2.01), and having two or more affected relatives with lung cancer further increased the risk of lung cancer with OR 3.60 (95%CI: 1.56–8.31). Among subjects aged less than 50, the OR for FH of lung cancer was 2.08 (95%CI: 1.18–3.63). The associations were generally stronger for squamous cell carcinoma and large cell carcinoma subtypes. Heterogeneity in results was not found with respect to smoking status and gender. A significant association was not observed for FH of other smoking-related tumors. The results of meta-analysis were consistent with that of our study with regard to young onset, non-smokers and histology. FH of lung cancer is a predictor of an increased risk of lung cancer, especially in subjects aged less than 50.
Appendix
Available only for authorised users
Literature
1.
Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P (2009) Cancer incidence in five Continents, vol.IX.IARC Scientific Publications No 160
2.
Peto R, Lopez A, Boreham J, Thun M (2006) Mortality from smoking in developed countries 1950-2000. CTSU, Oxford
3.
Brennan P, Crispo A, Zaridze D et al (2006) High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am J Epidemiol 164:1233–1241CrossRefPubMed
4.
Spitz MR, Hong WK, Amos CI et al (2007) A risk model for prediction of lung cancer. J Natl Cancer Inst 99:715–726CrossRefPubMed
5.
Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer in humans. J Natl Cancer Inst 30:289–312PubMed
6.
Matakidou A, Eisen T, Houlston RS (2005) Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 93:825–833CrossRefPubMed
7.
Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE (1999) Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 17:253–273CrossRefPubMed
8.
Sellers TA, Chen PL, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC (1994) Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet 52:308–314CrossRefPubMed
9.
Amos CI, Wu X, Broderick P et al (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40:616–622CrossRefPubMed
10.
Hung RJ, McKay JD, Gaborieau V et al (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633–637CrossRefPubMed
11.
Thorgeirsson TE, Geller F, Sulem P et al (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638–642CrossRefPubMed
12.
McKay JD, Hung RJ, Gaborieau V et al (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40:1404–1406CrossRefPubMed
13.
Bailey-Wilson JE, Amos CI, Pinney SM et al (2004) A major lung cancer susceptibility locus maps to chromosome 6q23–25. Am J Hum Genet 75:460–474CrossRefPubMed
14.
Xu H, Spitz MR, Amos CI, Shete S (2005) Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet 116:121–127CrossRefPubMed
15.
Liu P, Vikis HG, Wang D et al (2008) Familial aggregation of common sequence variants on 15q24–25.1 in lung cancer. J Natl Cancer Inst 100:1326–1330CrossRefPubMed
16.
Spitz MR, Amos CI, Dong Q, Lin J, Wu X (2008) The CHRNA5–A3 region on chromosome 15q24–25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100:1552–1556CrossRefPubMed
17.
Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS (2010) Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 31:234–238CrossRefPubMed
18.
19.
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefPubMed
20.
Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMed
21.
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefPubMed
22.
Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20:641–654CrossRefPubMed
23.
Wu PF, Lee CH, Wang MJ et al (2004) Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan. Eur J Cancer 40:260–266CrossRefPubMed
24.
Liu ZY, He XZ, Chapman RS (1991) Smoking and other risk factors for lung cancer in Xuanwei, China. Int J Epidemiol 20:26–31CrossRefPubMed
25.
Horwitz RI, Smaldone LF, Viscoli CM (1988) An ecogenetic hypothesis for lung cancer in women. Arch Intern Med 148:2609–2612CrossRefPubMed
26.
Wang TJ, Zhou BS, Shi JP (1996) Lung cancer in nonsmoking Chinese women: a case-control study. Lung Cancer 14(1):S93–S98CrossRefPubMed
27.
Tsugane S, Watanabe S, Sugimura H, Arimoto H, Shimosato Y, Suemasu K (1987) Smoking, occupation and family history in lung cancer patients under fifty years of age. Jpn J Clin Oncol 17:309–317PubMed
28.
Wang XR, Yu IT, Chiu YL et al (2009) Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control 20:757–763CrossRefPubMed
29.
Osann KE (1991) Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 51:4893–4897PubMed
30.
Schwartz AG, Yang P, Swanson GM (1996) Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144:554–562PubMed
31.
Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer among hospital patients. Public Health Rep 78:277–283PubMed
32.
Gorlova OY, Zhang Y, Schabath MB et al (2006) Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer 118:1798–1804CrossRefPubMed
33.
Wunsch-Filho V, Boffetta P, Colin D, Moncau JE (2002) Familial cancer aggregation and the risk of lung cancer. Sao Paulo Med J 120:38–44PubMed
34.
Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H (1986) Increased familial risk for lung cancer. J Natl Cancer Inst 76:217–222PubMed
35.
Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE (1988) Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 48:7279–7284PubMed
36.
McDuffie HH (1991) Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 44:69–76CrossRefPubMed
37.
Neuberger JS, Mahnken JD, Mayo MS, Field RW (2006) Risk factors for lung cancer in Iowa women: implications for prevention. Cancer Detect Prev 30:158–167CrossRefPubMed
38.
Kramer A, Graham S, Burnett W, Nasca P (1987) Familial aggregation of lung cancer stratified by smoking. Am J Epidemiol 126:766 (abstract)
39.
Mayne ST, Buenconsejo J, Janerich DT (1999) Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidemiol Biomarkers Prev 8:1065–1069PubMed
40.
Samet JM, Humble CG, Pathak DR (1986) Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 134:466–470PubMed
41.
Cassidy A, Myles JP, Duffy SW, Liloglou T, Field JK (2006) Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. Br J Cancer 95:1288–1290CrossRefPubMed
42.
Brownson RC, Alavanja MC, Caporaso N, Berger E, Chang JC (1997) Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. Int J Epidemiol 26:256–263CrossRefPubMed
43.
Wu AH, Fontham ET, Reynolds P et al (1996) Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 143:535–542PubMed
44.
45.
Cote ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG (2005) Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA 293:3036–3042CrossRefPubMed
46.
Cassidy A, Balsan J, Vesin A et al. (2009) Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case-control study in Europe. Eur J Cancer 45(17):3047–3053CrossRefPubMed
47.
Jin YT, Xu YC, Yang RD, Huang CF, Xu CW, He XZ (2005) Familial aggregation of lung cancer in a high incidence area in China. Br J Cancer 92:1321–1325CrossRefPubMed
48.
Etzel CJ, Amos CI, Spitz MR (2003) Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res 63:8531–8535PubMed
49.
Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA (1991) Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 44:429–437CrossRefPubMed
50.
Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH (2000) Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol 152:497–505CrossRefPubMed
51.
Wu-Williams AH, Dai XD, Blot W et al (1990) Lung cancer among women in north-east China. Br J Cancer 62:982–987PubMed
52.
Rachtan J, Sokolowski A, Niepsuj S, Zemla B, Zwierko M (2009) Familial lung cancer risk among women in Poland. Lung Cancer 65(2):138–143CrossRefPubMed
53.
Matakidou A, Eisen T, Bridle H, O’Brien M, Mutch R, Houlston RS (2005) Case-control study of familial lung cancer risks in UK women. Int J Cancer 116:445–450CrossRefPubMed
54.
Gao Y, Goldstein AM, Consonni D et al (2009) Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer 125:146–152CrossRefPubMed
55.
Kreuzer M, Kreienbrock L, Gerken M et al (1998) Risk factors for lung cancer in young adults. Am J Epidemiol 147:1028–1037PubMed
56.
Zhang Y, Shu XO, Gao YT et al (2007) Family history of cancer and risk of lung cancer among nonsmoking Chinese women. Cancer Epidemiol Biomarkers Prev 16:2432–2435CrossRefPubMed
57.
Nitadori J, Inoue M, Iwasaki M et al (2006) Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest 130:968–975CrossRefPubMed
58.
Poole CA, Byers T, Calle EE, Bondy J, Fain P, Rodriguez C (1999) Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol 149:454–462PubMed
59.
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608CrossRefPubMed
60.
Jonsson S, Thorsteinsdottir U, Gudbjartsson DF et al (2004) Familial risk of lung carcinoma in the Icelandic population. JAMA 292:2977–2983CrossRefPubMed
61.
Li X, Hemminki K (2005) Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer 47:301–307CrossRefPubMed
62.
Khoury MJ, Flanders WD (1995) Bias in using family history as a risk factor in case-control studies of disease. Epidemiology 6:511–519CrossRefPubMed
63.
Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC (1994) Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 47:89–96CrossRefPubMed
64.
Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98:61–68PubMedCrossRef
Metadata
Title
Family history and lung cancer risk: international multicentre case–control study in Eastern and Central Europe and meta-analyses
Authors
Jolanta Lissowska
Lenka Foretova
Joanna Dąbek
David Zaridze
Neonila Szeszenia-Dabrowska
Peter Rudnai
Eleonora Fabianova
Adrian Cassidy
Dana Mates
Vladimir Bencko
Vladimir Janout
Rayjean J. Hung
Paul Brennan
Paolo Boffetta
Publication date
01-07-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 7/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9537-2

Other articles of this Issue 7/2010

Cancer Causes & Control 7/2010 Go to the issue

Brief report

Poverty and childhood cancer incidence in the United States

Original paper

History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study

Original paper

Racial differences in PSA screening interval and stage at diagnosis

Original paper

Case–control study of lifetime total physical activity and endometrial cancer risk

Original paper

Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population

Review article

Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits